Evonik announced today that it opened a new facility for drying aqueous dispersions of EUDRAGIT polymers at its site in Darmstadt, Germany. The new, double-digit million-euro excipient manufacturing facility enables the Essen, Germany-based company to meet increasing demand from pharmaceutical customers for oral drug delivery solutions. EUDRAGIT polymers — polymethacrylates — are suitable for use…
Evonik launches new Eudratec tech to boost solubility of oral small molecules
Evonik (Essen, Germany) announced today that it now offers Eudratec SoluFlow, a microparticle technology meant to enhance solubility of active pharmaceutical ingredients in oral drug products. The emulsion-based process technology overcomes solubility hurdles that cannot be resolved by existing manufacturing technologies, according to Evonik. With more than 70% of new small molecules being insoluble, Eudratec…
How silica can support cold chain logistics
In the early days of the pandemic, the subarctic storage requirements for mRNA COVID-19 vaccines sparked renewed interest in the cold chain. One potentially overlooked element of the cold chain is silica, according to the specialty chemicals company Evonik. The company states that its Aerosil fumed silica supports passively cold transport units using cool packs…
Evonik investing $28m on initial expansion in Germany
Evonik recently announced that it will spend an initial €25 million (equivalent to nearly $28 million) to expand its Dossenheim and Hanau facilities in Germany. The expansion is meant to meet the growing demand for the contract manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates within Europe. Evonik expects to complete the €25 million…